Human Immunodeficiency Virus and Tuberculosis Coinfection at Fort Portal Regional Referral Hospital

Subscribe to access this work and thousands more

ABSTRACT Background; Worldwide, tuberculosis (TB) is one of the top 10 causes of death, and the principal cause from a single infectious agent (above HIV/AIDS); millions of people continue to fall sick with the disease to each year, HIV and TB alone or as coinfections, are a significant public health problem in the world with the biggest contribution to morbidity and mortality felt in sub-Saharan Africa. The immunosuppressive state caused by the decline in immunity as a result of HIV enables TB transmission, infection, reactivation and spread to extra-pulmonary sites making tuberculosis a major opportunistic infection in HIV patients. This study aimed to assess the prevalence of TB/HIV infection, EPTB and any adverse effects it might have on treatment adherence and overall outcome Method; A review of records retrospective study design was employed that made use of both qualitative and quantitative approaches. A total of 384 TB cases took part in the study, 12% of whom were also HIV infected. The prevalence of EPTB was 9.90% with no adverse effects on treatment adherence and overall outcome. Result; Records reviewed showed that physician-reported cases of EPTB documented among 384 TB patients. 38 cases of EPTB were reported while the remaining 346 were categorized into PTB. The prevalence of EPTB was thus 9.90% and that of PTB 90.10% with no adverse effects on treatment adherence and overall outcome. Conclusion; The prevalence of TB/HIV coinfection was high at 12% though not as high as estimates from previous studies elsewhere. This notwithstanding, urgent interventions are needed to reverse this. The prevalence of EPTB was low at 9.9%, values far lower than estimates of previous studies. Treatment adherence was not adversely affected by TB/HIV coinfection and for this reason no unfavourable outcomes were reported. 2 case-fatality rates were reported in the patients with a diagnosis of TBM

Subscribe to access this work and thousands more
Save
Overall Rating

0

5 Star
(0)
4 Star
(0)
3 Star
(0)
2 Star
(0)
1 Star
(0)
APA

Frontiers, E. & YUSUF, A (2022). Human Immunodeficiency Virus and Tuberculosis Coinfection at Fort Portal Regional Referral Hospital. Afribary. Retrieved from https://afribary.com/works/human-immunodeficiency-virus-and-tuberculosis-coinfection-at-fort-portal-regional-referral-hospital

MLA 8th

Frontiers, Edu, and AMINU YUSUF "Human Immunodeficiency Virus and Tuberculosis Coinfection at Fort Portal Regional Referral Hospital" Afribary. Afribary, 18 Aug. 2022, https://afribary.com/works/human-immunodeficiency-virus-and-tuberculosis-coinfection-at-fort-portal-regional-referral-hospital. Accessed 02 Oct. 2022.

MLA7

Frontiers, Edu, and AMINU YUSUF . "Human Immunodeficiency Virus and Tuberculosis Coinfection at Fort Portal Regional Referral Hospital". Afribary, Afribary, 18 Aug. 2022. Web. 02 Oct. 2022. < https://afribary.com/works/human-immunodeficiency-virus-and-tuberculosis-coinfection-at-fort-portal-regional-referral-hospital >.

Chicago

Frontiers, Edu and YUSUF, AMINU . "Human Immunodeficiency Virus and Tuberculosis Coinfection at Fort Portal Regional Referral Hospital" Afribary (2022). Accessed October 02, 2022. https://afribary.com/works/human-immunodeficiency-virus-and-tuberculosis-coinfection-at-fort-portal-regional-referral-hospital